Celltrion announces positive top-line results from global Phase III trial of regdanvimab (CT-P59), an anti-COVID-19 monoclonal antibody treatment

Must Read

infected animals was confirmed with a clinical dosage of regdanvimab (CT-P59)1
Incheon, South Korea–(Antara/Business Wire.

Latest News

Police uncover gold smuggling scheme using gel concealment

Jakarta (ANTARA) - The Indonesian National Police's Criminal Investigation Agency (Bareskrim) has uncovered an alleged illegal gold smuggling scheme...

More Articles Like This